相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
Guangwen Ren et al.
STEM CELLS (2009)
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
Guangwen Ren et al.
CELL STEM CELL (2008)
IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
David Polchert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Paulo C. Rodriguez et al.
IMMUNOLOGICAL REVIEWS (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
H. Ning et al.
LEUKEMIA (2008)
Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells
Farshad Forouzandeh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Hnmunomodulatory properties of mesenchymal stromal cells
Alma J. Nauta et al.
BLOOD (2007)
Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
J. M. Ryan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Biology of stem cells in human umbilical cord stroma:: In situ and in vitro surveys
Sercin Karahuseyinoglu et al.
STEM CELLS (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Multipotent mesenchymal stromal cells and immune tolerance
Daniele Noel et al.
LEUKEMIA & LYMPHOMA (2007)
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Kazuya Sato et al.
BLOOD (2007)
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Alma J. Nauta et al.
BLOOD (2006)
Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands
M. Tsuji
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Olle Ringden et al.
TRANSPLANTATION (2006)
Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells
Mauro Krampera et al.
STEM CELLS (2006)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase
DH Munn et al.
IMMUNITY (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease
JH Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
Immunotherapy with ligands of natural killer T cells
MT Wilson et al.
TRENDS IN MOLECULAR MEDICINE (2002)